Table 4.

Duration of BPSS-P Mania and General Symptoms Rated at Moderate or Higher Severity Since Onset (Weeks)

	BD-NOS (n = 29), median (Q1–Q3)	MD-NOS (n = 23), median (Q1–Q3)
BPSS-P mania symptoms	20.4 (12.1–30.7)	11.7 (6.1–28.4)
1. Mood elevation	20.1 (8.3–31.9)	12 (7.3–40.3)
2. Irritability	20.4 (12.1–30.7)	10.2 (5.3–14.6)
3. Inflated self-esteem/grandiosity	16.4 (0.7–18.2)	4.9 (0.54–43.6)
4. Decreased need for sleep	27.4 (13.7–32.9)	14.57 (11.21–48.07)
5. Over-talkativeness	20.3 (13–30.9)	14.43 (5–34.07)
6. Racing thoughts/flight of ideas	21.4 (15.4–27.7)	12.71 (8.07–37.75)
7. Distractibility	22.4 (12.7–31.1)	8.71 (5.86–12.86)
8. Increased energy/goal-directed activity	23.3 (7.5 33.2)	34.64 (28.43–40.86)
9. Increased psychomotor activity	24.9 (15–31.6)	11.86 (7.86–18.14)
10. Reckless or dangerous behavior	16.4 (7.4–20.9)	8.43 (2.57–14.21)
BPSS-P general symptoms	21.6 (14.9–30.7)	12.0 (7–28.4)
1. Mood lability	20.4 (8.3–30.3)	12 (6.1–28.4)
2. Oppositionality	22 (16.6–30.9)	8.6 (3.7–21)
3. Anger/aggressiveness	21 (8.3–31.2)	10.2 (5.3–18.1)
4. Anxiety	25.5 (18.5–32)	13.2 (8.5–37.7)
5. Self-injurious behavior	21 (15.6–30.1)	24.1 (10.1–46)
6. Obsessions and compulsions	15.4 (1.1–17.9)	11.6 (8.7–14.4)

BD-NOS, bipolar disorder not otherwise specified; BPSS-P, bipolar prodrome symptom scale-prospective; MD-NOS, mood disorder not otherwise specified; Q1, first quartile (P25); Q3, third quartile (P75).